NCT04473781View on ClinicalTrials.gov

Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

July 16, 2020

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2027

Conditions
Stage I Renal Cell CancerStage II Renal Cell Cancer
Interventions
PROCEDURE

Interstitial Radiation Therapy

Undergo interstitial brachytherapy

Trial Locations (1)

90095

RECRUITING

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

Jonsson Comprehensive Cancer Center

OTHER

NCT04473781 - Interstitial Brachytherapy for the Treatment of Unresectable/Unablatable Kidney Cancer | Biotech Hunter | Biotech Hunter